SummaryS h t y patients with fractured neck of femur and scheduled for surgical correction were randomly allocated to receiue one of three anaesthetic techniques: general anaesthesia: spinalana1gesia;psoas compartment block. The patienis in the local anaesthetic groups also received a light general anaesthetic. There was liitle difference in the pre-, intra-and postoperatiue euents, and no difference in postoperative mortality.
Renal cell carcinoma (RCC) commonly metastasizes to areas such as the lungs, liver, bone, brain, adrenals, and lymph nodes. We present a rare case of a 59-year-old female patient with RCC metastasis to the gallbladder. The patient had undergone right nephrectomy for RCC more than 6 years prior to the metastasis. During routine follow-up, a polypoid lesion of the gallbladder was identified. Laparoscopic cholecystectomy was performed, and pathologic examination of the specimen revealed metastatic RCC. The patient was completely asymptomatic, which reinforces the importance of postoperative follow-up. Renal cell carcinoma is one of the few common malignancies for which there is good evidence of survival benefit from surgical resection of the metastatic tumours.
(Group Prop; n = 14) and the other isoflurane/alfentanil (Group [so; n = 13)
. Periods of haemodynamic instability were correlated to episodes of myocardial ischaemia as assessed by Holter monitoring (begun the evening before surgery and ceasing the morning 9.t" the first postoperative day). In Group Prop, anaesthesia was induced with alfentanil 30 #g" kg -z iv, propofol up to L5 rag" kg -t and vecuronium 0.15 mg" kg -z, and maintained with infusions of propofol at 3-12 mg" kg -t" hr -1 and alfen-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.